FRT vs VANI · rev $1.28B vs $99.2M cap
FRT (FRT) versus Vivani Medical Inc. (VANI) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Vivani Medical Inc. (VANI) is a biotechnology company listed on NASDAQ.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported VANI revenue for 2025-06-30 was $0. Net income was -$13.4M. VANI currently screens at market cap $99.2M.
FRT currently screens at market cap $0. VANI currently screens at market cap $99.2M.
Not investment advice. Open the FRT and VANI stock pages for the full models.
Not investment advice.